Ebola survivors Zaizay Mulbah (left), a former money changer, and Mark Jerry, previously a delivery driver, are working as nurses' assistants at a Liberian Ebola centre.
out well because they made predictions that survived testing. Yet numerous his torical examples point to how, in the absence of adequate data, elegant and compelling ideas led researchers in the wrong direction, from Ptolemy's geocen tric theories of the cosmos to Lord Kel vin's 'vortex theory' of the atom and Fred Hoyle's perpetual steadystate Universe.
The consequences of overclaiming the significance of certain theories are pro found -the scientific method is at stake (see go.nature.com/hh7mm6). To state that a theory is so good that its existence supplants the need for data and testing in our opinion risks misleading students and the public as to how science should be done and could open the door for pseudoscientists to claim that their ideas meet similar requirements.
What to do about it? Physicists, philosophers and other scientists should hammer out a new narrative for the sci entific method that can deal with the scope of modern physics. In our view, the issue boils down to clarifying one question: what potential observational or experimental evidence is there that would persuade you that the theory is wrong and lead you to abandoning it? If there is none, it is not a scientific theory.
Such a case must be made in formal philosophical terms. A conference should be convened next year to take the first steps. People from both sides of the testability debate must be involved.
In the meantime, journal editors and publishers could assign speculative work to other research categories -such as mathematical rather than physical cos mology -according to its potential testability. And the domination of some physics departments and institutes by such activities could be rethought 1, 2 . Examples of the approach can be seen in Sierra Leone, Guinea and Liberia. For instance, the UN is training survivors to support children who have had contact with infected individuals and are within Ebola's 21day incubation window (the time it takes to develop symptoms after being infected with the virus). MSF is similarly employing survivors to work in their Ebola treatment units in Guinea and Liberia.
There are uncertainties about the ulti mate size of this cadre and, crucially, about the immunity of recovered responders to reinfection, both immediately and in the longer term (because immunity may wane). Nonetheless, the potential of MORE to shift the epidemic's dynamics makes its consid eration imperative.
RECOVERED RESPONDERS
So far, Ebola has infected an estimated 16,000 individuals in Liberia, Sierra Leone and Guinea. Current estimates suggest that in West Africa, roughly 50% of people who contract Ebola will die 2 . This would leave a substantial pool of survivors, totalling per haps 8,000 people by the end of the year. In the longer term, this could prove to be a much larger number. Indeed, the larger the epidemic, the bigger this pool becomes.
The worstcase projections of the US Centers for Disease Control and Preven tion, for Sierra Leone and Liberia only, range from 500,000 to 1.4 million cases of Ebola by January 2015 (ref.
3). Owing to various methodological limitations (set forth earlier by one of us, J.M.E., see go.nature.com/86kpyw), these projec tions are proving to be much too high. But even if the lower of these estimates turns out to be an order of magnitude too high, there could ultimately be 50,000 cases. If 50% survive, this is a pool of 25,000. If we assume that 75% of survivors would be too young, too old, too ill or too traumatized to be recruited, the available cadre could still number in the thousands (see go.nature. com/kbx4el).
There are limited confirmatory data on protective immunity to Ebola in humans. But researchers generally agree that the evi dence is pointing towards survivors being immune to reinfection. Thus far, there has not been a single reported case of a person who recovered from Zaire ebolavirus (the lineage of the current outbreak) becoming reinfected. This, and evidence from animal studies, suggests that people may have pro tective immunity following recovery.
RISK LEVEL
At worst, recovered responders would have the same level of risk as the general popula tion, in which case they would need to use the same personal protective equipment (PPE) as other responders. At best, they would have high protection through con ferred immunity.
In the latter event, recovered respond ers could operate with much less onerous PPE than current healthcare workers. They would require only the training and protec tive equipment (medical gloves, face shield and goggles) used to minimize the transmis sion of more familiar bloodborne patho gens such as HIV. This would allow them to have much more extensive contact with patients than Ebola PPE normally affords. Generally, providers in full Ebola PPE work only twohour shifts to avoid overheating (see go.nature.com/hsk4v5).
Recovered individuals can be trained to perform many important response func tions (see 'Responder roles'). Some of these are beyond palliative, and may have a direct impact on disease transmission, changing the course of the epidemic itself. Such activi ties include isolating suspected patients from uninfected community members
In classical epidemiology, susceptible people (S) bump into infected ones (I) as in a perfectly mixed bowl. That is, if β is the transmission probability per contact between these pools, the epidemic grows at rate βSI.
To model the impact of the MObilization of REcovered individuals (MORE) strategy, we let Z t denote the recovered proportion of the population t days into the epidemic, and k denote the fraction of recovered people who are deployed to reduce transmission. This multiplies the classical growth rate above by (1 -kZ t ), which one might interpret as reducing β.
The reproductive number, R t , is the average number of primary infections produced by a single infected individual dropped into the population on day t. If R t > 1 the epidemic is growing, whereas if R t < 1, it is declining. So, R t = 1 is the epidemic threshold. Letting R t M and R t C denote, respectively, the reproductive numbers in the MORE and classical models (including deaths), it follows that:
So, if k (the mobilized fraction of the recovered) exceeds zero, MORE reduces the reproductive number. And crucially, if R t = 1 or is hovering above it, mobilized survivors could tip the epidemic into fading out. More-realistic models, with social networks rather than perfect mixing, could reveal stronger effects. COMMENT and safely transporting them to treatment centres early in the course of infection, when viral loads and contagiousness are lowest. Performing simple tasks that do not require extensive training -such as giv ing people food and water, helping them to shower or feeding infants -would free specialized healthcare workers to concen trate on more sophisticated clinical tasks. Recovered responders could also perform duties such as waste disposal and decon tamination in highrisk areas ('hot zones') and ensure safe burial practices, all of which reduce the spread of the virus.
EBOLA CONTROL
As well as reducing Ebola transmission, MORE could enhance West African health infrastructure. It will generate a form of human capital that will continue to facilitate routine health care and the early warning of Ebola recurrence when the international presence declines. Furthermore, recovered responders would be important allies in any vaccination campaign.
TIPPING POINT
Most importantly, mobilizing the recovered to reduce transmission could 'tip' the epi demic into decline. Specifically, a central idea in epidemic modelling is the reproduc tive number of the disease, denoted by R t (see 'Reversing the epidemic'). This is inter preted as the average number of primary infections produced by a single infected individual dropped into the population at a particular time, t. If everyone is already ill there is no one to infect, R t is effectively zero.
By contrast, the very first infectious person introduced into a dense, uninfected population might transmit the disease to many, so the reproductive number at this time (t = 0) would be high. If R t is greater than 1, the epidemic is growing: each infected person is converting more than one susceptible person into another infec tive person. If R t is less than 1, the epidemic is shrinking. Therefore, the state at which R t is equal to 1 can be considered a tipping point. Above this point, the disease takes off. Below it, the epidemic dies away. MORE could reduce R t ; in countries currently close to the tipping point, such as Liberia, the strategy could bring R t below 1 and keep it there.
The World Bank is poised to spend almost US$500 million on foreign response for West Africa. With the economies of the most affected countries severely strained, this external support is crucial. By comparison, a small investment could establish a comple mentary standing cadre of local recovered responders. (Liberia's nurses, for example, are paid roughly $10 per day.) This strategy would create local jobs paying a fair wage in places where these are in short supply.
TACKLING STIGMA
A serious concern is that Ebola survivors are stigmatized. This was true of HIV in the early stages of the AIDS epidemic. There, stigma and social marginalization were successfully reduced with intensive educational campaigns and the support of national and international leaders 4 . Similar tactics can be employed here, but much ear lier, and with potentially dramatic effects. In fact, local survivor support groups and other efforts are already leading the way (see go.nature.com/t1xv4f).
MSF has begun providing 'certificates of recovery' to survivors, as a means of allay ing fears. Community volunteers in Sierra Leone and Liberia are working to combat misplaced fear: by visiting the neighbours of survivors before their return home; by broadcasting on radio and television; and by physically embracing survivors them selves. Socialmedia campaigns are rein forcing the message that people are not defined by their disease -among these are the 'I am a Liberian, not a virus!' and the 'I survived Ebola' campaigns.
If these campaigns are effective, peo ple infected with -or at risk of -Ebola may be particularly responsive to local survivors, who share their cultures, cus toms and language. In addition, recovered responders may themselves benefit from the work, improving their own psycho logical recovery.
High levels of illiteracy could be a concern insofar as they preclude highly specialized training. But for many of the tasks that we have highlighted, only limited training is required. People could be screened 5 and assigned functions on the basis of their preferences, aspirations, capabilities and work experience.
Crucial to the success of the MORE strategy is implementation on a broad scale. Although several groups are sporadically using survivors, the designation of a cen tral body to implement and manage MORE would facilitate an efficient broadening of the approach. The WHO is currently the lead organization for the international Ebola virus disease response, and it has direct rela tionships with local governments, ministries of health and response organizations working on the ground. An alternative lead organiza tion, MSF, is already working in this arena. MSF has substantial experience in managing volunteers in clinical environments and has comprehensive train ing programmes for various skill levels. A joint initiative of the WHO and MSF might be the best option for coordi nated and effective implementation of MORE. An urgent pri ority is to establish precisely which indi viduals indeed have protective immunity. This requires the identification of markers associated with immunity in the blood and serum of survivors 6 . Largescale in vivo epidemiological studies will be impor tant in solving this problem. Only then will we know the full potential of MORE. Meanwhile, recovered responders could perform tasks for which immunity is not essential, or use PPE where it is, as immedi ate steps in this promising direction. ■
